RE: Constant selling pressure2 Apr 2023 21:32
Manchester, UK - 31 March 2023: genedrive plc (LSE: GDR), the point of care molecular diagnostics company, is pleased to announce that it has agreed terms on an Equity Prepayment Facility for up to £5 million (the "Facility") with Riverfort Global Opportunities PCC Limited (the "Investors"), with an initial drawn amount of £2 million, expected to be received by the Company in early April 2023, net of associated costs.